Bio-Rad Laboratories (BIO) Non-Current Assets (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Non-Current Assets for 18 consecutive years, with $7.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 2.32% year-over-year to $7.2 billion in Q2 2026; TTM through Jun 2026 was $28.6 billion, a 2.99% increase from a year earlier, with the FY2025 full-year figure at $7.7 billion, up 21.1% from the prior year.
• Non-Current Assets was $7.2 billion for Q2 2026 at Bio-Rad Laboratories, up from $6.8 billion in the prior quarter.
• Over five years, Non-Current Assets peaked at $11.1 billion in Q1 2022 and troughed at $6.3 billion in Q4 2024.
• A 5-year average of $8.3 billion and a median of $8.2 billion in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets sank 49.0% in 2022 and grew 21.1% in 2025, its largest moves.
• Over 5 years, Non-Current Assets stood at $10.3 billion in 2022, then retreated by 10.57% to $9.3 billion in 2023, then tumbled by 31.53% to $6.3 billion in 2024, then gained by 21.1% to $7.7 billion in 2025, then dropped by 5.72% to $7.2 billion in 2026.
• The last three Non-Current Assets figures came in at $7.2 billion (Q2 2026), $6.8 billion (Q1 2026), and $7.7 billion (Q4 2025), per Business Quant data.